No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study

Thyroid

Volumn 27, Issue 2, 2017, Pages 147-155

  Wouters, Hanneke J C M ^a   Van Loon, Hannah C M ^a   Van Der Klauw, Melanie M ^a   Elderson, Martin F ^a   Slagter, Sandra N ^a   Kobold, Anneke Muller ^a   Kema, Ido P ^a   Links, Thera P ^a   Van Vliet Ostaptchouk, Jana V ^a   Wolffenbuttel, Bruce H R ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

deiodinase 2; executive functioning; free T4; general population; polymorphism; quality of life; TSH

Indexed keywords

ALANINE; THREONINE; THYROID HORMONE; THYROTROPIN; THYROXINE DEIODINASE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II; LIOTHYRONINE; THYROXINE;

ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; COGNITION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FIGURAL FLUENCY TEST; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMOZYGOTE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID FUNCTION; AGED; BLOOD; CASE CONTROL STUDY; GENETICS; HEALTH STATUS; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; CASE-CONTROL STUDIES; COGNITION; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY OF LIFE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 85011321317     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2016.0199     Document Type: Article

References (46)

1. Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC 2014 The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 99:923-931
2. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM; American Thyroid Association Task Force on Thyroid Hormone Replacement 2014 Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24:1670-1751
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534
4. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM 2002 Psychological well-being in patients on ''adequate'' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57:577-585
5. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, VanderpumpMP2012 2012 ETAGuidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 1:55-71
6. Gullo D, Latina A, Frasca F, LeMoli R, Pellegriti G, VigneriR 2011 Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PloS One 6:e22552
7. Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC, Koutras DA 2005 TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr 117:636-640
8. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. 1999 Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340:424-429
9. Escobar-Morreale HF, Botella-Carretero JI, Morreale de EscobarG2015Treatment of hypothyroidismwith levothyroxine or a combination of levothyroxine plus L-triiodothyronine. Best Pract Res Clin Endocrinol Metab 29:57-75
10. Davis JD, Tremont G 2007 Neuropsychiatric aspects of hypothyroidism and treatment reversibility.Minerva Endocrinol 32:49-65
11. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG, Wiersinga WM 2005 Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153:747-753
12. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R 1990 Thyroidal and peripheral production of 3,5,3-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 258:E715-726
13. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
14. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-2888
15. PeetersRP, van den BeldAW,Attalki H, Toor H, de RijkeYB, Kuiper GG, Lamberts SW, Janssen JA, Uitterlinden AG, Visser TJ 2005A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab 289:E75-81
16. de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ, Breteler MM 2007 The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92:636-640
17. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM, Frayling TM 2008A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 93:3075-3081
18. Taylor PN, Razvi S, Pearce SH, Dayan CM 2013 Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab 98:3562-3571
19. Celi FS, Canettieri G, Mentuccia D, Proietti-Pannunzi L, Fumarola A, Sibilla R, Predazzi V, Ferraro M, Andreoli M, Centanni M 2000 Structural organization and chromosomal localization of the human type II deiodinase gene. Eur J Endocrinol 143:267-271
20. Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S, Trischitta V 2008 Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab 93:910-913
21. Grarup N, Andersen MK, Andreasen CH, Albrechtsen A, Borch-Johnsen K, Jorgensen T, Auwerx J, Schmitz O,Hansen T, Pedersen O 2007 Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. J Clin Endocrinol Metab 92:363-366
22. Verloop H, Dekkers OM, Peeters RP, Schoones JW, Smit JW 2014 Genetics in endocrinology: genetic variation in deiodinases: a systematic review of potential clinical effects in humans. Eur J Endocrinol 171:R123-135
23. Wartofsky L 2013 Combination L-T3 and L-T4 therapy for hypothyroidism. Curr Opin Endocrinol Diabetes Obes 20: 460-466
24. Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, FraylingTM,DayanCM2009 Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. JClin EndocrinolMetab 94:1623-1629
25. McAninch EA, Bianco AC 2015 New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism. Lancet Diabetes Endocrinol 3:756-758
26. Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, Vonk JM, van Dijk F, van Zon SK, Wijmenga C, Wolffenbuttel BH, Stolk RP 2015 Cohort profile: LifeLines, a threegeneration cohort study and biobank. Int J Epidemiol 44:1172-1180
27. Klaver EI, van Loon HC, Stienstra R, Links TP, Keers JC, Kema IP, Muller Kobold AC, van der Klauw MM, Wolffenbuttel BH 2013 Thyroid hormone status and health-related quality of life in the LifeLines cohort study.Thyroid 23:1066-1073
28. Boelen A, Kwakkel J, Alkemade A, Renckens R, Kaptein E, Kuiper G, WiersingaWM, Visser TJ 2005 Induction of type 3 deiodinase activity in inflammatory cells ofmice with chronic local inflammation. Endocrinology 146:5128-5134
29. VanderZee KI, Sanderman R, Heyink JW, de HH 1996 Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med 3:104-122
30. Slagter SN, van Vliet-Ostaptchouk JV, van Beek AP, Keers JC, Lutgers HL, van der Klauw MM, Wolffenbuttel BH 2015 Health-related quality of life in relation to obesity grade, type 2 diabetes, metabolic syndrome and inflammation. PloS One 10:e0140599
31. van Eersel ME, Joosten H, Koerts J, Gansevoort RT, Slaets JP, Izaks GJ 2015 Longitudinal study of performance on the Ruff Figural Fluency Test in persons aged 35 years or older. PLOS ONE 10:e0121411
32. Jansen H, Stolk RP, Nolte IM, Kema IP, Wolffenbuttel BH, Snieder H 2013 Determinants of HbA1c in nondiabetic Dutch adults: genetic loci and clinical and lifestyle parameters, and their interactions in the LifeLines cohort study. J Intern Med 273:283-293
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
34. Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzagt F, Hui S, Hendrie HC 2006 Comorbidity profile of dementia patients in primary care: are they sicker J Am Geriatr Soc 54:104-109
35. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. 2009 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
36. McAninch EA, Jo S, Preite NZ, Farkas E, Mohacsik P, Fekete C, Egri P,GerebenB,LiY,DengY, PattiME,Zevenbergen C, Peeters RP, Mash DC, Bianco AC 2015 Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. J Clin Endocrinol Metab 100:920-933
37. Butler PW, Smith SM, Linderman JD, Brychta RJ, Alberobello AT, Dubaz OM, Luzon JA, Skarulis MC, Cochran CS, Wesley RA, Pucino F, Celi FS 2010 The Thr92Ala 5 type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study. Thyroid 20:1407-1412
38. Heemstra KA, Hoftijzer HC, van der DeureWM, Peeters RP, Fliers E, Appelhof BC, Wiersinga WM, Corssmit EP, Visser TJ, Smit JW 2009 Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) 71:279-283
39. Santoro AB, Vargens DD, Barros Filho Mde C, Bulzico DA, Kowalski LP, Meirelles RM, Paula DP, Neves RR, Pessoa CN, Struchine CJ, Suarez-Kurtz G 2014 Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on Lthyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. Br J Clin Pharmacol 78:1067-1075
40. Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Fliers E 2005 Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3-triiodothyronine therapy. J Clin Endocrinol Metab 90:6296-6299
41. Ruff RM, Light RH, Evans RW 1987 The Ruff Figural Fluency Test: a normative study with adults. Devel Neuropsychol 3:37-51
42. Brummelman P, Elderson MF, Dullaart RP, van den Bergh AC, Timmer CA, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, van Beek AP 2011 Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf) 74:481-487
43. Izaks GJ, Joosten H, Koerts J, Gansevoort RT, Slaets JP 2011 Reference data for the Ruff Figural Fluency Test stratified by age and educational level. PloS One 6:e17045
44. Samuels MH, Kolobova I, Smeraglio A, Peters D, Janowsky JS, Schuff KG 2014 The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition. J Clin Endocrinol Metab 99:843-851
45. SamuelsMH, SchuffKG,CarlsonNE,Carello P, Janowsky JS 2007 Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 17:249-258
46. Callebaut I, Curcio-Morelli C, Mornon JP, Gereben B, Buettner C, Huang S, Castro B, Fonseca TL, Harney JW, Larsen PR, Bianco AC 2003 The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem 278:36887-36896.